申请人:OPKO Health, Inc.
公开号:US20140336158A1
公开(公告)日:2014-11-13
A NK
1
antagonist having the formula (I),
wherein Ar
1
and Ar
2
are optionally substituted phenyl or heteroaryl, X
1
is an ether, thio or imino linkage, R
4
and R
5
are not both H or alkyl, and the remaining variables are as defined in the specification, useful for treating a number of disorders, including emesis, depression, anxiety and cough. Pharmaceutical compositions. Methods of treatment and combinations with other agents are also disclosed.
一种具有公式(I)的NK1拮抗剂,其中Ar1和Ar2是可选择取代的苯基或杂环芳基,X1是醚,硫或亚胺键,R4和R5不都是H或烷基,其余变量如规范中所定义,可用于治疗多种疾病,包括恶心、抑郁、焦虑和咳嗽。制药组合物。还揭示了治疗方法和与其他药物的组合。